about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Rid­ing on rosy es­ti­mates of Zol­gens­ma sales, Re­genxBio sells part of its roy­al­ty for $200M

5 years ago
Deals
Cell/Gene Tx

Trump par­dons Chris Collins, for­mer con­gress­man im­pris­oned for biotech in­sid­er trad­ing scan­dal

5 years ago
People

Months af­ter strik­ing SHP2 deal with Ab­b­Vie, Ja­co­bio pulls in $174M+ from Hong Kong IPO

5 years ago
Financing
China

Go­ing head-to-head with Eylea, Roche touts PhI­II win for bis­pe­cif­ic block­buster con­tender in di­a­bet­ic mac­u­lar ede­ma

5 years ago
R&D

For­mer J&J VP sues phar­ma gi­ant for discim­i­na­tion and ha­rass­ment, ac­cus­es top ex­ecs — in­clud­ing Alex Gorsky — of ...

5 years ago
People

No­var­tis' biotech part­ner ad­mits PhI­II Covid-19 de­feat for stem cell ther­a­py, trig­ger­ing ex­ten­sion of $1.2B+ deal ...

5 years ago
R&D
Coronavirus

Covid-19 roundup: FDA gives OK to use ex­tra dos­es in Pfiz­er/BioN­Tech vac­cine vials; Sinophar­m's Pe­ru tri­al to re­sume

5 years ago
Coronavirus

Ab­b­Vie's Covid-19 an­ti­body part­ner wraps $221M Hong Kong IPO

5 years ago
Financing
China

Build­ing its neu­ro pipeline, No­var­tis antes up $210M cash to buy a biotech part­ner drug­ging 'both fla­vors' of NM­DA

5 years ago
Deals

Trou­bled AB Sci­ence claims break­out Alzheimer's suc­cess while vTv flops — again

5 years ago
R&D

Out of CRISPR pi­o­neer David Li­u's lab comes a small mol­e­cule play tar­get­ing ex­osites — and it's raised a mod­est ...

5 years ago
Financing
Startups

News brief­ing: FDA ap­proves oint­ment for pre­can­cer skin le­sions; Take­da nabs pri­or­i­ty re­view for Shire drug

5 years ago
News Briefing

Al­lo­gene, Over­land plot speedy Asia play for off-the-shelf CAR-T with $117M joint ven­ture

5 years ago
Financing
R&D

Sanofi, No­vo back a small biotech that's neck and neck with Pfiz­er to de­vel­op a Group B strep­to­coc­cus vac­cine

5 years ago
Financing

Go­ing to Chi­na? ADC Ther­a­peu­tics spot­lights a new way to do it with Hill­house-backed Over­land

5 years ago
Deals
China

Chas­ing Am­gen on KRAS com­bo, Roche dish­es out $75M for Re­lay's SHP2 drug to pair with in-house pro­gram

5 years ago
Deals

Covid-19 roundup: Trump walks back plans to pri­or­i­tize White House staff for vac­cine; As­traZeneca drops sub­group of ...

5 years ago
Coronavirus

News brief­ing: CG On­col­o­gy nets $47M Se­ries D for blad­der can­cer stud­ies; Sin­gle-cell tran­scrip­tom­ic start­up rais­es ...

5 years ago
News Briefing

Mar­ry­ing pre­ci­sion med and AI, Groupon co-founder Er­ic Lefkof­sky takes to­tal haul for his an­a­lyt­ics firm over the $1B ...

5 years ago
Financing

No­var­tis’ $9.7B PC­SK9 drug nabs first OK — now comes the chal­lenge of find­ing a mar­ket

5 years ago
FDA+

An­gling for a spot among the gi­ants, TG Ther­a­peu­tics touts PhI­II MS da­ta for CD20 drug

5 years ago
R&D

'S­cale and speed': Hill­house puts its weight be­hind Chi­na start­up eye­ing cut­ting-edge tech from around the world

5 years ago
Startups
China

Boehringer In­gel­heim bags a con­tract man­u­fac­tur­er, adding mus­cles for can­cer vac­cine, on­colyt­ic virus pro­grams

5 years ago
Deals

Covid-19 roundup: UAE claims Sinopharm vac­cine 86% ef­fec­tive, but de­tails are scant; In­dia re­port­ed­ly re­jects ...

5 years ago
Coronavirus
First page Previous page 59606162636465 Next page Last page
A service from the Financial Times